This statistic shows the leading pharmaceutical and biotechnology companies in the United Kingdom (UK) in 2015, based on market value. The values are based on the 2015 Financial Times Global 500 list. In this year GlaxoSmithKline ranked highest on the list with a market value worth 75.2 billion British pounds. GlaxoSmithKline also ranks among the top biotech companies by profit.The Anglo-Swedish firm, AstraZeneca followed with a market value of around 58.5 billion British pounds.
GlaxoSmithKline is a British pharmaceutical company with its headquarters based in London, United Kingdom. The company manufactures products for major disease areas including respiratory disorders such as asthma, oncology, immuno-inflammatory disorders, cardiovascular diseases, as well as manufacturing vaccinations. One of the most successful drugs manufactured and patented by GSK was Seretide/Advair which is used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). In 2016, sales of the drug Seretide/Advair generated a revenue of 835 million British pounds in Europe.
Leading pharmaceutical and biotechnology companies in the United Kingdom (UK) in 2015, based on market value (in million GBP)
Exclusive Premium Statistic
This statistic shows the leading pharmaceutical and biotechnology companies in the United Kingdom (UK) in 2015, based on market value. The values are based on the 2015 Financial Times Global 500 list. In this year GlaxoSmithKline ranked highest on the list with a market value worth 75.2 billion British pounds. GlaxoSmithKline also ranks among the top biotech companies by profit.The Anglo-Swedish firm, AstraZeneca followed with a market value of around 58.5 billion British pounds.
GlaxoSmithKline is a British pharmaceutical company with its headquarters based in London, United Kingdom. The company manufactures products for major disease areas including respiratory disorders such as asthma, oncology, immuno-inflammatory disorders, cardiovascular diseases, as well as manufacturing vaccinations. One of the most successful drugs manufactured and patented by GSK was Seretide/Advair which is used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). In 2016, sales of the drug Seretide/Advair generated a revenue of 835 million British pounds in Europe.
More information
Statista Accounts: Access All Statistics. Starting from $588 / Year
Statistics on "Pharmaceutical industry in the United Kingdom (UK)"
Popular Related Keywords
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Percentage return on R&D among large cap biopharma companies 2010-2017
- Top pharma and biotech companies by sales growth in 2016-2017
- Top pharmaceutical and biotech companies by profit growth in 2016/2017
- Amount of top U.S. biotech venture financings 2017
- U.S. venture funding of therapeutic companies by disease type 2017
- Projection of top 10 global pharmaceutical companies by revenue 2018
- Enterprise value of top companies in non-oncology rare disease therapeutics 2017
- Market cap of select pharma companies with strong pipeline 2017
- Leading global pharmaceutical risers based on share price 2017
- U.S. number of IPOs for neurology companies 2006-2017
- R&D cost to develop new pharmaceutical compounds 2010-2017
- Revenue shares of big pharma as of 2017, by business strategy
- Percentage return on R&D among mid cap biopharma companies 2013-2017
- U.S. venture investments in infectious disease companies from 2006 to 2017
- Cost to bring biopharmaceutical assets in mid cap companies to market 2010-2017
- Animal health leading companies by revenue 2017
- Biopharmaceutical companies by turnover size band in the UK 2017
- Hyperimmunes market share in U.S. by company 2016
- Latin America: biopharmaceuticals revenue 2016-2021
- Romania: water supply, sewerage and waste disposal industry turnover 2008-2015
